ImmuCell

Immucell Corporation was originally founded in Maine in 1982 and reorganized in Delaware in 1987 along with its initial public offering of common stock. The purpose of Immucell Corporation is to create scientifically validated practical products that will have a significant economic impact on animal health, the dairy industry, and the beef industry. Immucell is a publicly traded biotechnology company engaged in the research, development, production, and sale of products that improve animal health and enhance dairy and beef production. The company’s product focus includes the prevention, diagnosis, and treatment of diseases in bovine animals with important economic benefits.